ATE534729T1 - Hepatitis-b-virus-dna-polymerase und oberflächenantigen-varianten und methoden iher verwendung - Google Patents
Hepatitis-b-virus-dna-polymerase und oberflächenantigen-varianten und methoden iher verwendungInfo
- Publication number
- ATE534729T1 ATE534729T1 AT01937883T AT01937883T ATE534729T1 AT E534729 T1 ATE534729 T1 AT E534729T1 AT 01937883 T AT01937883 T AT 01937883T AT 01937883 T AT01937883 T AT 01937883T AT E534729 T1 ATE534729 T1 AT E534729T1
- Authority
- AT
- Austria
- Prior art keywords
- variants
- viral
- hepatitis
- present
- virus
- Prior art date
Links
- 241000700721 Hepatitis B virus Species 0.000 title abstract 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 title 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 230000003612 virological effect Effects 0.000 abstract 5
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 238000003556 assay Methods 0.000 abstract 2
- 230000001747 exhibiting effect Effects 0.000 abstract 2
- 229940127073 nucleoside analogue Drugs 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 230000001900 immune effect Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
- 230000035945 sensitivity Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1252—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Communicable Diseases (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPQ8109A AUPQ810900A0 (en) | 2000-06-09 | 2000-06-09 | Viral variants and methods of using same |
| PCT/AU2001/000690 WO2001094559A1 (en) | 2000-06-09 | 2001-06-08 | Hepatitis b virus dna polymerase and surface antigen variants and methods of using same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE534729T1 true ATE534729T1 (de) | 2011-12-15 |
Family
ID=3822180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01937883T ATE534729T1 (de) | 2000-06-09 | 2001-06-08 | Hepatitis-b-virus-dna-polymerase und oberflächenantigen-varianten und methoden iher verwendung |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7431933B2 (de) |
| EP (2) | EP2360243B1 (de) |
| AT (1) | ATE534729T1 (de) |
| AU (2) | AUPQ810900A0 (de) |
| CA (1) | CA2409983C (de) |
| ES (2) | ES2630024T3 (de) |
| WO (1) | WO2001094559A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPO351996A0 (en) * | 1996-11-08 | 1996-12-05 | Western Health Care Network | Viral variants and methods for detecting same |
| AUPQ810900A0 (en) | 2000-06-09 | 2000-07-06 | Austin and Repatriation Medical Centre, The | Viral variants and methods of using same |
| US7405039B2 (en) | 2002-02-07 | 2008-07-29 | Austin Health | Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| EP2319917A3 (de) * | 2002-02-07 | 2012-02-08 | Melbourne Health | Virus Varianten mit veränderter Empfindlichkeit gegenüber Nukleosidanalogen und Verwendungen davon |
| AU2003202301B8 (en) * | 2002-02-07 | 2009-01-08 | Austin Health | Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| WO2003087351A1 (en) * | 2002-04-12 | 2003-10-23 | Melbourne Health | Hepatitis b viral variants with redused susceptibility to nucleoside analogs and uses thereof |
| AU2003213874B2 (en) * | 2002-04-12 | 2008-12-04 | Austin Health | Hepatitis B viral variants with redused susceptibility to nucleoside analogs and uses thereof |
| US7875423B2 (en) | 2003-10-21 | 2011-01-25 | Melbourne Health | HBV variants detection and application |
| AU2006230802A1 (en) | 2005-04-08 | 2006-10-12 | Austin Health | Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof |
| JP2008534020A (ja) | 2005-04-08 | 2008-08-28 | メルボルン ヘルス | 抗ウイルス性のヌクレオシド剤に耐性を示すｂ型肝炎ウイルスのバリアントおよびその応用法 |
| EP3788377A1 (de) * | 2018-05-04 | 2021-03-10 | Abbott Laboratories | Hbv-diagnostische, prognostische und therapeutische verfahren und produkte |
| CN109609694B (zh) * | 2018-12-29 | 2022-03-01 | 上海昂朴生物科技有限公司 | 基于Illumina测序技术检测乙型肝炎分型及多耐药位点的试剂盒及方法 |
| CN117778346A (zh) * | 2022-09-27 | 2024-03-29 | 南京普济生物有限公司 | 一种dna聚合酶及其制备方法和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPO351996A0 (en) * | 1996-11-08 | 1996-12-05 | Western Health Care Network | Viral variants and methods for detecting same |
| UA73475C2 (en) * | 1998-06-19 | 2005-08-15 | Government Of Republic Singapo | Hepatitis b virus strain, induced by vaccine, nucleic acid isolated molecule coding mutant main surface antiigen of hepatitis b virus, vector and vector system for the preparation of polypeptide, a method for the preparation of polypeptide (variants), purified polypeptide (variants), oligonucleotide, a method for the preparation of antibodies (variants), antibody (variants), a method for the determination of chemical compound for treating the infection of hepatitis b strain infection, a composition, a method for the preparation of composition, a method of organism liquids screening for hepatitis b virus, a method of antibody use, vaccine against hepatitis |
| AUPP706098A0 (en) * | 1998-11-11 | 1998-12-03 | North Western Health Care Network | Biological compositions, components thereof and uses therefor |
| AUPP967999A0 (en) * | 1999-04-09 | 1999-05-06 | North Western Health Care Network | Viral variants |
| AUPQ810900A0 (en) | 2000-06-09 | 2000-07-06 | Austin and Repatriation Medical Centre, The | Viral variants and methods of using same |
-
2000
- 2000-06-09 AU AUPQ8109A patent/AUPQ810900A0/en not_active Abandoned
-
2001
- 2001-06-08 US US10/297,664 patent/US7431933B2/en not_active Expired - Lifetime
- 2001-06-08 EP EP10182339.1A patent/EP2360243B1/de not_active Expired - Lifetime
- 2001-06-08 EP EP01937883A patent/EP1297109B1/de not_active Expired - Lifetime
- 2001-06-08 CA CA2409983A patent/CA2409983C/en not_active Expired - Lifetime
- 2001-06-08 ES ES10182339.1T patent/ES2630024T3/es not_active Expired - Lifetime
- 2001-06-08 AT AT01937883T patent/ATE534729T1/de active
- 2001-06-08 AU AU6367201A patent/AU6367201A/xx active Pending
- 2001-06-08 ES ES01937883T patent/ES2384343T3/es not_active Expired - Lifetime
- 2001-06-08 WO PCT/AU2001/000690 patent/WO2001094559A1/en not_active Ceased
-
2008
- 2008-10-06 US US12/245,994 patent/US7931907B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| HK1053144A1 (en) | 2003-10-10 |
| US7931907B2 (en) | 2011-04-26 |
| ES2630024T3 (es) | 2017-08-17 |
| ES2384343T3 (es) | 2012-07-04 |
| EP1297109B1 (de) | 2011-11-23 |
| US7431933B2 (en) | 2008-10-07 |
| EP2360243A1 (de) | 2011-08-24 |
| AUPQ810900A0 (en) | 2000-07-06 |
| EP1297109A4 (de) | 2004-12-29 |
| WO2001094559A1 (en) | 2001-12-13 |
| CA2409983A1 (en) | 2001-12-13 |
| EP2360243B1 (de) | 2017-05-03 |
| CA2409983C (en) | 2012-02-21 |
| AU6367201A (en) | 2001-12-17 |
| EP1297109A1 (de) | 2003-04-02 |
| US20040005541A1 (en) | 2004-01-08 |
| US20090155771A1 (en) | 2009-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE534729T1 (de) | Hepatitis-b-virus-dna-polymerase und oberflächenantigen-varianten und methoden iher verwendung | |
| EP1476543A4 (de) | Virusvarianten mit veränderter empfindlichkeit gegenüber nukleosidanalogen und verwendungen davon | |
| Zuckerman et al. | Mutations of the surface protein of hepatitis B virus | |
| DK1026262T3 (da) | Oligonukleotidprimere til effektiv detektering af hepatitis C-virus (HCV) og fremgangsmåder til anvendelse deraf | |
| DK1542732T3 (da) | Fusionsproteiner af Mycobacterium tuberculosis | |
| Mixson-Hayden et al. | Performance of ARCHITECT HCV core antigen test with specimens from US plasma donors and injecting drug users | |
| ES2139571T3 (es) | Ensayo de hepatitis c que utiliza antigenos recombinantes. | |
| HK1045324A1 (zh) | 病毒變體 | |
| WO2003002749A3 (en) | Methods for the simultaneous detection of hcv antigens and hcv antibodies | |
| WO2004016586A3 (en) | Compositions and methods related to flavivirus envelope protein domain iii antigens | |
| Gerken et al. | Clinical evaluation of a single reaction, diagnostic polymerase chain reaction assay for the detection of hepatitis C virus RNA | |
| DE602005027226D1 (de) | Varianten des hepatitis-b-virus mit resistenz gegenüber antiviralen nukleosidagentien und anwendungen davon | |
| BR0200986A (pt) | Ensaio de combinação anticorpo - antìgeno da hepatite c para a detecção precoce da infecção | |
| DK1035220T3 (da) | Oligonukleotidprimere til effektiv multiplekspåvisning af hepatitis C-virus (HCV) og human immunodefekt virus (HIV) samt fremgangsmåder til anvendelse deraf | |
| DE60239715D1 (de) | Nachweis des bovinen Virusdiarrhoe-Virus in Gewebeproben | |
| ATE552264T1 (de) | Neue oberflächenprotein- (hbsag-) variante des hepatitis b virus | |
| DE602005017790D1 (de) | Rt-pcr-verfahren zum quantitativen nachweis von hdv | |
| Mphahlele et al. | Age related prevalence of hepatitis G virus in South Africans. | |
| HK1121187A1 (zh) | 抗病毒耐药性突变体及其应用 | |
| ATE426038T1 (de) | Nachweis des rinderdiarrhoevirus in haarproben | |
| WO2006113522A3 (en) | Methods of detecting hepatitis c virus | |
| Carreno et al. | Hepatitis B Virus and Hepatitis C Virus: Molecular Biology and Diagnosis | |
| Haushofer et al. | Hepatitis B virus activity in patients with anti-hepatitis C virus antibody positivity and hepatitis B antigen positivity | |
| BR0206887A (pt) | Reagentes para a detecção simult nea de antìgenos e anticorpos de núcleo de do vìrus da hepatite c (hcv) | |
| TW200510545A (en) | HBV pre-core protein having particle-forming ability |